Sun Young Rha - Concepedia

Author

Sun Young Rha

Also Known As

Chung, Kenji Amagai, Panagiotis Samaras, R Winterhalder, R. Winterhalder, Ralph Winterhalder, Rha, S.Y., S Y Rha, S Young Rha, S. Rha

1.4K

Publications

37.1K

Citations

H-Index

202

Concepts

All Affiliations

Yonsei University Asan Medical Center University of Ulsan Ulsan College Yonsei University Health System

About

Sun Young Rha is an author at Yonsei University specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	211	14.9K
2	Health Sciences	24	40	2.5K
3	Engineering	6	6	337
4	Nursing	3	3	327
5	Natural Sciences	2	2	144

Sun Young Rha

454

Publications

30.7K

Citations

H-Index

Page 1

	Year	Citations
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha, New England Journal of Medicine	2021	1.7K
Bevacizumab in Combination With Chemotherapy As First-Line Therapy in Advanced Gastric Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study Atsushi Ohtsu, Manish A. Shah, Eric Van Cutsem, Journal of Clinical Oncology	2011	1.1K
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan, The Lancet Oncology External ValidationUrologyPopulation-based StudyGenitourinary CancerMedicine	2013	1K
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial Patrick Schöffski, Sant P. Chawla, Robert G. Maki, The Lancet OncologyMetronomic TherapyPharmacologyAdvanced LiposarcomaEribulin Versus Dacarbazine	2016	753
A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets Niantao Deng, Liang Kee Goh, Hannah Wang, Gut	2012	635
Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes Zhi Jiang Zang, Ioana Cutcutache, Song Ling Poon, Nature Genetics Cancer ResearchChromatinSomatic VariantTumor HeterogeneityExome Sequencing	2012	634
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial Sun Young Rha, Do‐Youn Oh, Patricio Yañez, The Lancet Oncology Chemotherapy Versus PlaceboGastrointestinal OncologyMedicineClinical TrialsImmune Checkpoint Inhibitor	2023	521
Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Keun Seok Lee, Hyun Cheol Chung, Seock Ah Im, Breast Cancer Research and Treatment Metastatic Breast CancerBreast OncologyPolymer-drug ConjugateMedicinePharmacology	2007	518
Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium Daniel Y.C. Heng, J. Connor Wells, Brian I. Rini, European Urology UrologySurgical OncologyGenitourinary CancerMedicineCytoreductive Nephrectomy	2014	467
Phase II Randomized Trial Comparing Sequential First-Line Everolimus and Second-Line Sunitinib Versus First-Line Sunitinib and Second-Line Everolimus in Patients With Metastatic Renal Cell Carcinoma Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, Journal of Clinical Oncology	2014	426

Page 1